Recently FDA and EMA released guidance to assist with co-development, but creation of a global registration strategy remains challenging. This session will bridge diverse regulatory perspectives to accelerate global co-development efforts.

Learning Objectives:
Summarize synergies and divergences between various health authority policies on co-development and co-registration
Apply information to form pragmatic global development and registration strategies for co-developed medical products.